US health agency estimates 27 million adults used GLP-1 drugs in 2025


Among users, 44% reported changing how they took the drugs. More than half of those making changes cited cost or availability, prompting the researchers to call for studies of dose and frequency adjustments.
Researchers at the Centers for Disease Control and Prevention (CDC) estimate that approximately 27 million US adults used GLP-1 medications in 2025. Among users, 44% said they took the drugs differently from how they were prescribed.
The estimates draw on survey responses from more than 8,000 US adults collected in July–August 2025. Ars Technica described the study in a 13 November 2026, article, saying the CDC had published it that week.
GLP-1 medications, short for glucagon-like peptide-1 receptor agonists, are used for diabetes, weight loss and other conditions. Reported changes included skipping doses, delaying refills and taking smaller doses than prescribed. More than half of those who changed their use cited cost or availability as reasons.
At least 23% of GLP-1 users reported taking a compounded version; another 9% did not know whether their medication was compounded. These versions are prepared by compounding pharmacies to mimic approved medications.
| Medication used | Share reporting changes |
|---|---|
| Compounded | 62% |
| Brand-name | 36% |
Compounded drugs are not themselves approved by the Food and Drug Administration (FDA). The agency does not review their safety, effectiveness or quality before sale. The CDC authors said understanding the safety and quality of compounded GLP-1 medications was an important public health consideration given their substantial use.

Analysis
The survey responses describe medication use and users’ stated reasons for changing it; they do not establish resulting clinical harms or causation. The CDC authors called for research on the safety and effectiveness of real-world dose and frequency adjustments. They said that evidence could help shape clinical guidelines and support appropriate medication use.

The fiscal 2027 proposal supports a civilian collision-warning system. The Trump administration requested $11 million for the office in charge, including $1 million for the system, while House appropriators proposed the same office funding as the Senate.
2 min

No contact developed Ebola, Nigeria’s disease-control agency said on 13 November. An official end to the outbreak still requires a separate 42-day countdown.
2 min

Researchers found that female elephant communities in Udawalawe became smaller and more isolated after losses began to outpace newcomers around 2012. By 2018, about 69% of females seen at the study’s start were no longer observed.
3 min